Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
11
65%
Ph phase_2
6
35%

Phase Distribution

0

Early Stage

6

Mid Stage

11

Late Stage

Phase Distribution17 total trials
Phase 2Efficacy & side effects
6(35.3%)
Phase 3Large-scale testing
11(64.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

17

all time

Status Distribution
Completed(12)
Other(5)

Detailed Status

Completed12
unknown4
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 26 (35.3%)
Phase 311 (64.7%)

Trials by Status

suspended16%
unknown424%
completed1271%

Recent Activity

0 active trials
Showing 5 of 17
completedphase_2

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

NCT00036868
completedphase_3

Tamoxifen in Treating Women With High-Risk Breast Cancer

NCT00002542
unknownphase_2

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

NCT00012311
completedphase_3

Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer

NCT00003893
completedphase_3

Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer

NCT00003577
View all 17 trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT00036868Phase 2

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

Completed
NCT00002542Phase 3

Tamoxifen in Treating Women With High-Risk Breast Cancer

Completed
NCT00012311Phase 2

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

Unknown
NCT00003893Phase 3

Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer

Completed
NCT00003577Phase 3

Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer

Completed
NCT00002498Phase 2

Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer

Unknown
NCT00002579Phase 3

Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer

Completed
NCT00003680Phase 3

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

Unknown
NCT00002755Phase 3

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Completed
NCT00003012Phase 3

Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer

Completed
NCT00003013Phase 3

Chemotherapy Plus Surgery in Treating Women With Breast Cancer

Completed
NCT00002582Phase 3

Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Completed
NCT00002696Phase 3

Combination Chemotherapy in Treating Women With Stage III Breast Cancer

Suspended
NCT00002784Phase 3

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer

Completed
NCT00003953Phase 2

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Completed
NCT00003549Phase 2

S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer

Completed
NCT00033683Phase 2

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Unknown

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17